Female fertility and age at menopause are determined by the number and quality of eggs stored in the ovaries. For unknown reasons, two-thirds of all eggs die soon after they are made. Furthermore, a serious side effect of cancer treatment is egg death resulting in infertility and early menopause. I am unravelling the genes involved in determining whether an egg will live or die. This understanding will help us develop novel strategies to preserve fertility during aging and cancer treatment.
Optimising Female Fertility: Controlling Ovulation And Promoting Embryo Developmental Potential
Funder
National Health and Medical Research Council
Funding Amount
$459,270.00
Summary
A good quality egg at the right time is required to make a healthy embryo, influencing its lifetime health trajectory. My research aims to determine how the female ovary produces a good quality egg and releases it at the right time. This is essential for improving reproductive health in women and will identify how maternal health influences egg quality and the earliest stages of embryo growth, providing the healthiest start to life.
Interleukin 11 And Leukaemia Inhibitory Factor: Important Regulators Of Embryo Implantation And Placentation
Funder
National Health and Medical Research Council
Funding Amount
$346,117.00
Summary
Infertility, spontaneous abortion and pre-eclampsia are major clinical problems. Interleukin (IL)-11 and leukemia inhibitory factor (LIF) are critical for embryo implantation in mice but their roles in women are unknown. I will define their roles in the establishment of pregnancy and provide new critical information on their potential as targets for diagnostic and therapeutic tools for infertility and major diseases associated with pregnancy.